Average Co-Inventor Count = 6.14
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Warner-lambert Company (13 from 2,538 patents)
2. Everist Genomics, Inc. (1 from 4 patents)
14 patents:
1. 9234245 - Prognostic signature for colorectal cancer recurrence
2. 7786131 - Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases
3. 6713484 - Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
4. 6602863 - Irreversible inhibitors of tyrosine kinases
5. 6596726 - Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
6. 6521620 - Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
7. 6498163 - Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
8. 6455534 - Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
9. 6344459 - Irreversible inhibitors of tyrosine kinases
10. 6265410 - Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11. 6084095 - Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine
12. 5721266 - Substituted imidazolinyl-imidazolines as antagonists of SH-2 binding and
13. 5679683 - Tricyclic compounds capable of inhibiting tyrosine kinases of the
14. 5654307 - Bicyclic compounds capable of inhibiting tyrosine kinases of the